XML 21 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Share-Based Compensation
 9 Months Ended
Nov. 02, 2019
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
For the thirty-nine weeks ended November 2, 2019 and November 3, 2018, share-based compensation expense was $5.4 million and $15.5 million, respectively. As of November 2, 2019, approximately 4.3 million shares remain available for future grants of equity awards under our Amended and Restated 2012 Omnibus Stock and Incentive Plan (the "Amended Omnibus Plan"), which was amended and restated effective June 22, 2017.
Restricted Stock Awards
Restricted stock awards vest in equal annual installments over a three-year period from the date of grant, except for a restricted stock award granted to our CEO, which vests over a four-year period from the date of grant and is described further in the Company’s Current Report on Form 8-K/A filed with the SEC on August 20, 2019.
Restricted stock award activity for the thirty-nine weeks ended November 2, 2019 was as follows:

Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
2,715,466

 
$
10.92

Granted
3,563,105

 
4.22

Vested
(1,266,059
)
 
11.28

Forfeited
(1,638,433
)
 
7.11

Unvested, end of period
3,374,079

 
5.56


Performance-based Restricted Stock Units
For the thirty-nine weeks ended November 2, 2019, we granted performance-based restricted stock units ("PSUs"), contingent upon the achievement of Company-specific performance goals. The annual PSU grants in March 2019 have a performance period of the three fiscal years 2019 - 2021. Special PSU grants in August and October 2019 have a performance period of part of fiscal year 2019 through the end of fiscal year 2021. Any units earned as a result of the achievement of the performance goals of the PSUs will vest three years from the date of grant for the March 2019 grants and in March 2022 for the August and October 2019 grants and will be settled in shares of our common stock. All PSUs granted during the thirty-nine weeks ended November 2, 2019 were granted under our Amended Omnibus Plan, except for one PSU granted as an inducement award as permitted under New York Stock Exchange Rule 303A.08. The inducement award was granted to our CEO outside of the Amended Omnibus Plan and is described further in the Company’s Current Report on Form 8-K/A filed with the SEC on August 20, 2019.
Performance-based restricted stock unit activity for the thirty-nine weeks ended November 2, 2019 was as follows:
 
Number of Units/
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
1,067,338

 
$
11.40

Granted
2,740,650

 
2.87

Vested
(244,628
)
 
13.19

Forfeited
(1,297,434
)
 
7.24

Unvested, end of period
2,265,926

 
3.27


Stock Option Awards
For the thirty-nine weeks ended November 2, 2019 and November 3, 2018, we did not grant any stock options.
Stock option activity for the thirty-nine weeks ended November 2, 2019 was as follows:
 
Number of
Options
 
Weighted
 Average
Exercise Price
Outstanding, beginning of period
214,277

 
$
13.54

Granted
—

 
—

Exercised
—

 
—

Forfeited or expired
(2,000
)
 
13.26

Outstanding and exercisable, end of period
212,277

 
13.54